Bioventix PLC (AIM:BVXP)
London · Delayed Price · Currency is GBP · Price in GBX 2,400.00
-25.00 (-1.03%)
Oct 10, 2025, 3:45 PM GMT+1
Bioventix Market Cap
Bioventix has a market cap or net worth of 125.40 million as of October 10, 2025. Its market cap has decreased by -38.40% in one year.
Market Cap
125.40M
Enterprise Value
120.25M
Revenue
13.66M
Ranking
n/a
PE Ratio
16.20
Stock Price
2,400.00
Market Cap Chart
Since April 8, 2010, Bioventix's market cap has increased from 9.85M to 125.40M, an increase of 1,173.39%. That is a compound annual growth rate of 17.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 125.40M | -24.33% |
| Dec 31, 2024 | 165.72M | -26.16% |
| Dec 29, 2023 | 224.45M | 7.98% |
| Dec 30, 2022 | 207.85M | 17.35% |
| Dec 31, 2021 | 177.12M | -22.46% |
| Dec 31, 2020 | 228.43M | 34.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 198.58B |
| GSK plc | 65.20B |
| Haleon | 30.37B |
| Smith & Nephew | 11.52B |
| ConvaTec Group | 4.82B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 2.04B |
| Genus | 1.68B |